Literature DB >> 624770

Persistence of immunoglobulin G and immunoglobulin M antibodies after postnatal rubella infection determined by solid-phase radioimmunoassay.

O H Meurman.   

Abstract

The appearance and persistence of immunoglobulin M (IgM) and IgG antibodies in postnatal rubella infections were studied by employing a solid-phase radioimmunoassay test. Altogether, 222 serial serum specimens from 51 patients with acute rubella infection were tested. Both IgG and IgM antibodies developed rapidly and appeared in all patients within 4 days after the onset of rash. In some patients, the IgM antibodies clearly preceded the IgG antibodies; however, the reverse situation was also noticed in a few cases. The IgG antibodies showed only minor changes after 8 to 10 days from the onset of rash. The IgM titers also reached a maximum level at approximately 8 to 10 days after the onset of rash, after which time a rapid decrease was normally seen. The mean half-life of IgM antibodies after 15 days from the onset of rash was 4.5 days, giving for IgM antibodies persistence times from 43 to approximately 80 days. Two patients with a prolonged IgM antibody response were detected. One of these patients had bilateral arthritis of the knee as a complication, whereas in the other patient no complication caused by rubella virus was detected. The IgM antibody response and its value in diagnosis are discussed.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 624770      PMCID: PMC274852          DOI: 10.1128/jcm.7.1.34-38.1978

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  28 in total

1.  METABOLISM OF HUMAN GAMMA MACROGLOBULINS.

Authors:  W F BARTH; R D WOCHNER; T A WALDMANN; J L FAHEY
Journal:  J Clin Invest       Date:  1964-06       Impact factor: 14.808

2.  Rubella, 1962.

Authors:  J Fry; J B Dillane; L Fry
Journal:  Br Med J       Date:  1962-09-29

3.  Estimation of rubella-specific IgM antibody in sera by single fraction collection on sephadex G-200.

Authors:  P J Pead
Journal:  Med Lab Technol       Date:  1974-04

4.  Rubella antibody in IgG and IgM immunoglobulins detected by immunofluorescence.

Authors:  S M Cohen; C P Ducharme; C A Carpenter; R Deibel
Journal:  J Lab Clin Med       Date:  1968-11

5.  Neutralizing antibody responses in the major immunoglobulin classes to yellow fever 17D vaccination of humans.

Authors:  T P Monath
Journal:  Am J Epidemiol       Date:  1971-02       Impact factor: 4.897

6.  The IgM antibody response in rubella during pregnancy.

Authors:  J Desmyter; M A South; W E Rawls
Journal:  J Med Microbiol       Date:  1971-02       Impact factor: 2.472

7.  A serological method for demonstrating recent infection by rubella virus.

Authors:  J E Banatvala; J M Best; E A Kennedy; E E Smith; M E Spence
Journal:  Br Med J       Date:  1967-07-29

8.  Antibody response to rubella virion (V) and soluble (S) antigens in rubella infection and following vaccination with live attenuated rubella virus.

Authors:  T Vesikari; A Vaheri; P Leinikki
Journal:  Arch Gesamte Virusforsch       Date:  1971

9.  IgG, IgA and IgM responses in acute rubella determined by the immunofluorescent technique.

Authors:  J E Cradock-Watson; M S Bourne; E M Vandervelde
Journal:  J Hyg (Lond)       Date:  1972-09

10.  Single-sample diagnosis of recent rubella by fractionation of antibody on Sephadex G-200 column.

Authors:  J D Gupta; V Peterson; M Stout; A M Murphy
Journal:  J Clin Pathol       Date:  1971-09       Impact factor: 3.411

View more
  12 in total

1.  Antibody responses in patients with rubella infection determined by passive hemagglutination, hemagglutination inhibition, complement fixation, and solid-phase radioimmunoassay tests.

Authors:  O H Meurman
Journal:  Infect Immun       Date:  1978-02       Impact factor: 3.441

2.  Humoral immunity against Francisella tularensis after natural infection.

Authors:  P Koskela; A Salminen
Journal:  J Clin Microbiol       Date:  1985-12       Impact factor: 5.948

3.  Circulating immune complexes in patients with acute measles and rubella virus infections.

Authors:  B Ziola; G Lund; O Meurman; A Salmi
Journal:  Infect Immun       Date:  1983-08       Impact factor: 3.441

4.  Cell-mediated and humoral immunity induced by a live Francisella tularensis vaccine.

Authors:  P Koskela; E Herva
Journal:  Infect Immun       Date:  1982-06       Impact factor: 3.441

5.  Rubella-specific immune complexes after congenital infection and vaccination.

Authors:  P K Coyle; J S Wolinsky; E Buimovici-Klein; R Moucha; L Z Cooper
Journal:  Infect Immun       Date:  1982-05       Impact factor: 3.441

6.  Does parvovirus B19 have a role in rheumatoid arthritis?

Authors:  S Nikkari; R Luukkainen; T Möttönen; O Meurman; P Hannonen; M Skurnik; P Toivanen
Journal:  Ann Rheum Dis       Date:  1994-02       Impact factor: 19.103

7.  Detection of anti-yellow fever virus immunoglobulin m antibodies at 3-4 years following yellow fever vaccination.

Authors:  Katherine B Gibney; Srilatha Edupuganti; Amanda J Panella; Olga I Kosoy; Mark J Delorey; Robert S Lanciotti; Mark J Mulligan; Marc Fischer; J Erin Staples
Journal:  Am J Trop Med Hyg       Date:  2012-10-29       Impact factor: 2.345

8.  Comparison of a simple latex agglutination test with hemolysis-in-gel, hemagglutination inhibition, and radioimmunoassay for detection of rubella virus antibodies.

Authors:  P Väänänen; V M Häivä; P Koskela; O Meurman
Journal:  J Clin Microbiol       Date:  1985-05       Impact factor: 5.948

9.  Hemadsorption immunosorbent technique for determination of rubella immunoglobulin M antibody.

Authors:  J T van der Logt; A M van Loon; J van der Veen
Journal:  J Clin Microbiol       Date:  1981-03       Impact factor: 5.948

10.  Time-resolved fluoroimmunoassay: a new test for rubella antibodies.

Authors:  O H Meurman; I A Hemmilä; T N Lövgren; P E Halonen
Journal:  J Clin Microbiol       Date:  1982-11       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.